Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Thoracic Malignancies
Would the presence of an SVC stent affect your decision to offer BID vs once-daily chemoradiation for SCLC?
Does the presence of an SVC stent preclude 60/40 or other BID dose escalation for SCLC?
Answer from: Radiation Oncologist at Community Practice
There is no evidence to guide the practice one way or the other. From a biological standard point, it should not.
Sign In
or
Register
to read more
30024
Related Questions
Would you give durvalumab consolidation to a patient with stage III NSCLC with an STK11 mutation?
Would you offer SBRT for primary pulmonary adenoid cystic carcinoma in a patient who was medically not a surgical candidate?
Would you consider omitting concurrent chemoradiation for a patient with stage III EGFR-mutant NSCLC and initiating treatment with osimertinib instead?
Is there a role for focal radiation in peritoneal mesothelioma following cytoreductive surgery/ HIPEC?
Is there evidence supporting the role of SBRT in the management of oligometastatic stage IV NSCLC?
How does neoadjuvant chemo-immunotherapy impact your decision on hypofractionation/dose fractionation for locally advanced NSCLC, now getting RT alone?
Can palliative radiation be used to treat recurrent malignant pleural effusion in NSCLC?
Would you treat a patient with an N2 ipsilateral recurrence following re-resection of bronchial stump recurrence?
What target expansions do you use when treating with 60 Gy in 15 fractions for the lung?
What radiation treatment volume would you include in chemoradiation given for perihilar lymph node recurrence after surgical resection and mediastinal lymph node dissection for NSCLC?